Eligibility criteria for clinical trials in AL amyloidosis result in exclusion of nearly half of real‐world patients

HemaSphere 2026 Open access

Read full text
Authors: Claudia Bellofiore, Marco Basset, Mario Nuvolone, Martina Nanci, Giuseppe Damiano Sanna, Valeria A. Di Simone, Alessandro Fogliani, Monica Di Cecca, Roberta Mussinelli, Andrea Foli, Matin Ghazi Esfahani, Mohammadjavad Sadrzadeh
+6 more Stefano Perlini, Leonardo De Luca, Solène Clavreul, Giampaolo Merlini, Giovanni Palladini, Paolo Milani
DOI: 10.1002/hem3.70320
Cited by: 1
References: 20

Fields of Study & Subjects

Amyloidosis: Diagnosis Treatment Outcomes Multiple Myeloma Research and Treatments Alzheimer's disease research and treatments

Publication details

Journal / source
HemaSphere
Publisher
Wiley
Volume
10
Issue
2
Pages
e70320–e70320
Publication date
1 February 2026
Language
EN